Home > Healthcare > Medical Devices > Medical Supplies > Tourniquet Systems Market
Tourniquet Systems Market size was valued at around USD 437 million in 2022 and is projected to reach over USD 941 million by 2032. This is owing to increasing prevalence of degenerative bone disorders and musculoskeletal diseases among adult population coupled with rising number of orthopedic surgeries.
Additionally, technological advancements pertaining to advance tourniquet systems in managing the blood flow during critical surgeries is estimated to increase the product demand. Rising healthcare spending for providing better healthcare infrastructure, increasing disposable income and consistently increasing geriatric population are some of the major factors responsible for increasing adoption of tourniquet systems across the world.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Tourniquet Systems Market Size in 2022: | USD 437 Million |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 8% |
2032 Value Projection: | USD 941 Million |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 180 |
Tables, Charts & Figures: | 421 |
Segments covered: | Component, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
A tourniquet system is a device that applies pressure to restrict the blood flow in an extremity, both arteries and veins, for a specific duration. It is primarily used in emergency situations and surgical procedures to control bleeding effectively. The lack of trained professionals proficient in using tourniquet systems is a notable challenge that may hinder market progress in the future. Adequate training in the utilization of these systems is vital for healthcare providers such as paramedics, EMTs, nurses, and doctors.
The tourniquet systems industry experienced a decline in revenue during the first half of 2020 due to the COVID-19 outbreak. The global healthcare sector, including tourniquet systems, was adversely affected by the pandemic, leading to a slowdown in market growth. The disruption caused by the outbreak included supply chain interruptions, manufacturing delays, limited access to raw materials, and logistical challenges, affecting the availability of tourniquet systems worldwide. However, as the number of COVID-19 cases decreased and healthcare services resumed, the market gradually recovered, returning to pre-pandemic procedural volumes.
Increasing prevalence of degenerative bone disorders and musculoskeletal diseases among adult population is expected to boost the market size. Degenerative bone disorders and musculoskeletal diseases often require surgical interventions for treatment. These may include fracture repairs, orthopaedic surgeries to address complications from these conditions.
For instance, according to the CDC, in the U.S., currently there are more than 2.6 million people that are affected by osteoporosis escalating the demand for orthopedic surgeries. Tourniquet systems are commonly used during these surgeries to achieve bloodless surgical fields, improve visibility for surgeons, and reduce blood loss. Therefore, increasing prevalence of degenerative bone disorders and musculoskeletal diseases, along with the aforementioned factors, are expected to contribute to a growing demand for tourniquet systems in surgical and orthopedic settings.
Based on component, the tourniquet systems market is segmented as tourniquet instruments and tourniquet cuffs. The tourniquet cuffs is further segmented as pneumatic and non-pneumatic systems. The pneumatic tourniquet cuffs is further bifurcated into disposable and reusable. The tourniquet cuffs held a dominant market share in 2022 accounting for more than 68% of the total market share. This is owing to several benefits offered by tourniquet cuffs during a variety of upper as well as lower limb surgeries.
This equipment inherit the capability to control haemorrhage and minimize blood loss, thereby improving visualization and efficiency during surgery. With improved visualization and controlled bleeding, surgeons can perform surgeries more efficiently and effectively. Therefore, owing to aforementioned factors and other advantages including less tissue trauma, precise pressure control, etc. is expected to augment the tourniquet systems industry landscape.
Based on application, the tourniquet systems market is segmented as upper-limb and lower-limb. The lower-limb accounted for major market share in 2022 and is expected to grow at 7.6% CAGR by 2032. Increasing prevalence of orthopedic surgeries is projected to augment the product demand. For instance, according to an article published by NCBI, in 2021, around 2.6 million people undergo knee replacement surgery across the globe. This incidence rate is anticipated to increase due to ageing population, degenerative bone disorder and rising trauma cases among others. Enhanced surgical precision, reduced blood loss, improved post-operative pain control are some of the major factors influencing the uptake of advance tourniquet systems in several healthcare facilities globally.
Based on end-use, the tourniquet systems market is segmented as hospitals, ambulatory surgical centers and others. The hospital segment is projected to grow at 7.9% CAGR from 2023-2032. This is owing to the availability of advanced tourniquet systems for the diagnosis and treatment of varied chronic ailments. Enhanced operability and accessibility to comprehensive range of treatments incorporating tourniquet systems is expected to drive the market revenue. Increasing admissions with orthopedic diseases, trauma and accidents and ageing related disorders are increasing the instances of hospitalizations with a robust healthcare system is expected to boost the industry size.
The U.S. tourniquet systems market is predicted to reach around USD 358 million by 2032. This is attributable to numerous variables including the presence of key market players, an increase in the number of chronic diseases, and rising awareness regarding the benefits of tourniquet systems for diagnosis and treatment of joint ailments among others.
For instance, according to the CDC report, in 2021, around 32 million people in the U.S. were suffering from osteoarthritis and is expected to increase in the near future. Tourniquet systems are one of the important devices used in diagnosis and treatment of these disorders. The higher incidence of these diseases has resulted in the surged number of minimally invasive procedures that is anticipated to fuel the product adoption rate.
Some of the major players operating in the tourniquet systems market are
These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion.
Click here to Buy Section of this Report
By Component, 2018 - 2032 (USD Million)
By Application, 2018 - 2032 (USD Million)
By End-use, 2018 - 2032 (USD Million)
The above information is provided for the following regions and countries: